Habit Building Software Application to Increase Engagement of Vulnerable Populations in the National Diabetes Prevention Program (NDPP) Lifestyle Change Program (LCP)
NCT ID: NCT06656273
Last Updated: 2024-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
450 participants
INTERVENTIONAL
2021-02-01
2022-10-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Do participants using the software application (the intervention group) have better engagement with the Diabetes Prevention Program than those who do not use the companion software application (the control group)? Are participants using the software application (the intervention group) more likely to stay in the Diabetes Prevention Program longer than those who do not use the companion software application (the control group)?
Participants are those who have signed up for their local Diabetes Prevention Program and agree to be in the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Developing and Testing a Technology-Based Translation of the DPP to Address Prediabetes in a Primary Care Setting
NCT04564586
MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes
NCT03193229
Healthy Living Partnership to Prevent Diabetes
NCT00631345
Study of a Diabetes Prevention Patient Activation Clinical Decision Support Tool
NCT06358261
Behavioral Nudges for Diabetes Prevention (BEGIN) Trial in Primary Care
NCT04869917
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FT LCP
FT LCP
FT LCP is a behavior change software application, used as an adjunct to the standard National Diabetes Prevention Program
Standard LCP
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FT LCP
FT LCP is a behavior change software application, used as an adjunct to the standard National Diabetes Prevention Program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* has a smartphone or other device able to engage with the FT LCP app
* can read basic 5th grade English, as used in the FT LCP app
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
The Institute for Iterative Thinking
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Institute of Iterative Thinking
Felton, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
75D30119C06604
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
1300367-20210112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.